Essa Pharma Inc. (EPIX) NASDAQ
$2.91 0.03 (1.04%)
Market Cap: $127.01M
As of 10/04/23 04:30 PM EDT. Market closed.

Essa Pharma Inc. (EPIX)
NASDAQ
$2.91
0.03 (1.04%)
Market Cap: $127.01M
As of 10/04/23 04:30 PM EDT. Market closed.
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical ... read more
as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in our approach. we're firmly rooted in creative and open thinking, giving us an energy and approach that makes us a different kind of pharmaceutical company. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Parkinson David Ross | Chief Executive Officer | Dec 30, 2022 | Buy | $2.60 | 3,067 | 7,974 | 56,542 | Jan 05, 2023, 06:18 PM |
Parkinson David Ross | Chief Executive Officer | Dec 22, 2022 | Buy | $2.39 | 21,367 | 51,067 | 53,475 | Jan 05, 2023, 06:18 PM |
BERGER FRANKLIN M | Director | Dec 16, 2022 | Sale | $2.67 | 50,000 | 133,500 | 800,244 | Jan 05, 2023, 03:41 PM |
BERGER FRANKLIN M | Director | Dec 15, 2022 | Sale | $2.88 | 82,000 | 235,800 | 900,244 | Jan 05, 2023, 03:41 PM |
BERGER FRANKLIN M | Director | Dec 14, 2022 | Sale | $3.00 | 25,000 | 75,000 | 932,244 | Jan 05, 2023, 03:41 PM |
BERGER FRANKLIN M | Director | Dec 21, 2022 | Sale | $2.41 | 72,223 | 174,401 | 718,738 | Jan 05, 2023, 03:41 PM |
BERGER FRANKLIN M | Director | Dec 20, 2022 | Sale | $2.53 | 43,617 | 110,351 | 756,627 | Jan 05, 2023, 03:41 PM |
Wood David S. | Chief Financial Officer | Dec 30, 2022 | Buy | $2.60 | 8,302 | 21,585 | 33,343 | Jan 05, 2023, 03:07 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 27, 2022 | Buy | $4.50 | 500,000 | 2,251,100 | 7,879,583 | Oct 28, 2022, 02:57 PM |
BIOTECH GROWTH N V | 10% Owner | Oct 26, 2022 | Buy | $3.98 | 1,500,000 | 5,968,500 | 7,379,583 | Oct 28, 2022, 02:57 PM |
BIOTECH GROWTH N V | 10% Owner | Jul 18, 2022 | Buy | $3.16 | 300,000 | 946,740 | 5,879,583 | Jul 20, 2022, 03:21 PM |
BIOTECH GROWTH N V | 10% Owner | Jul 15, 2022 | Buy | $3.13 | 241,665 | 756,798 | 5,579,583 | Jul 18, 2022, 12:48 PM |
BIOTECH GROWTH N V | 10% Owner | Jul 14, 2022 | Buy | $2.79 | 347,204 | 969,428 | 5,337,918 | Jul 18, 2022, 12:48 PM |
Parkinson David Ross | Chief Executive Officer | Jun 30, 2022 | Buy | $2.96 | 4,887 | 14,456 | 32,108 | Jul 05, 2022, 01:39 PM |
BIOTECH GROWTH N V | 10% Owner | Apr 27, 2022 | Sale | $5.85 | 25,100 | 146,925 | 4,990,714 | Apr 28, 2022, 12:28 PM |
BIOTECH GROWTH N V | 10% Owner | Aug 18, 2021 | Buy | $8.88 | 250,000 | 2,218,800 | 5,015,814 | Aug 20, 2021, 12:43 PM |
BERGER FRANKLIN M | Director | Feb 22, 2021 | Buy | $27.00 | 57,000 | 1,539,000 | 957,244 | Mar 04, 2021, 06:47 PM |
BERGER FRANKLIN M | Director | Dec 03, 2020 | Option Exercise | $3.64 | 42,207 | 153,701 | 900,244 | Jan 11, 2021, 04:42 PM |
Owner | Relationship | Date | Value($) |
Parkinson David Ross | Chief Executive Officer | 12/30/2022 | 7,974 |
Parkinson David Ross | Chief Executive Officer | 12/22/2022 | 51,067 |
BERGER FRANKLIN M | Director | 12/16/2022 | 133,500 |
BERGER FRANKLIN M | Director | 12/15/2022 | 235,800 |
BERGER FRANKLIN M | Director | 12/14/2022 | 75,000 |
BERGER FRANKLIN M | Director | 12/21/2022 | 174,401 |
BERGER FRANKLIN M | Director | 12/20/2022 | 110,351 |
Wood David S. | Chief Financial Officer | 12/30/2022 | 21,585 |
BIOTECH GROWTH N V | 10% Owner | 10/27/2022 | 2,251,100 |
BIOTECH GROWTH N V | 10% Owner | 10/26/2022 | 5,968,500 |
BIOTECH GROWTH N V | 10% Owner | 07/18/2022 | 946,740 |
BIOTECH GROWTH N V | 10% Owner | 07/15/2022 | 756,798 |
BIOTECH GROWTH N V | 10% Owner | 07/14/2022 | 969,428 |
Parkinson David Ross | Chief Executive Officer | 06/30/2022 | 14,456 |
BIOTECH GROWTH N V | 10% Owner | 04/27/2022 | 146,925 |
BIOTECH GROWTH N V | 10% Owner | 08/18/2021 | 2,218,800 |
BERGER FRANKLIN M | Director | 02/22/2021 | 1,539,000 |
BERGER FRANKLIN M | Director | 12/03/2020 | 153,701 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,042,531 | 0.00612% | No change | Other |
ORBIMED ADVISORS LLC | 921,940 | 0.05% | -23.07% | Other |
D. E. SHAW & CO., INC. | 168,050 | 0.00046% | -2.42% | Other |
DRIEHAUS CAPITAL MANAGEMENT LLC | 28,300 | 0.00096% | -89.3% | Growth |
GEODE CAPITAL MANAGEMENT, LLC | 19,039 | 0.00001% | No change | Other |
BLACKROCK INC. | 2,261 | 0% | No change | Other |
Period of Report: 06/30/2023
10-K/10-Q Filings: View